Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Research has shown that HIV with reduced drug susceptibility is prevalent in 26% of newly infected patients, and in 75% of patients failing triple combination therapy. As drug resistance becomes a more significant factor in antiviral therapy, it could potentially change how HIV is treated.
Copyright © 2001 - The Positive Direction. Brought to you courtesy of The Positive Direction. Reproduction of this article (other than one copy for personal reference) must be cleared through the copyright owner.
ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
This information is designed to support, not replace, the relationship that exists between you and your doctor.